Poised For Outsized Growth – Guardant Health, Inc. (GH)

Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Guardant Health, Inc. (GH) was $92.97. Currently, the 1st Resistance Point for this stock is $96.82, with a 2nd Resistance Point sitting at $100.66. Meanwhile, this company’s stock has a 1st Support Level at $87.87 and a 2nd Support Level at $82.76. Guardant Health, Inc. (GH) stock has gained $9.55, or 11.45%, in the past five days. In the last full month, these shares have gained $4.15, or 4.67%. In the past three months, this stock’s price has risen by $18.95, or 25.60%. This year-to-date, Guardant Health, Inc. (GH) shares have gained $55.38, or 147.33%.

Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Guardant Health, Inc. (GH) stock, 100% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 100% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 100% of long-term indicators suggest that this stock is a “ Buy .”

With 87,113 K shares outstanding, this company currently has a market capitalization of $8,098,895K. Guardant Health, Inc. (GH) generates $90,640 K in annual sales, amounting to annual net income of -$85,060 K. This stock has generated a 1-Year Total Return of 188.73%, a 3-Year Total Return of 0.00%, and a 5-year Total Return of 0.00%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.

For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is -$0.34 per share. This estimate came from a total of 4 Wall Street Analysts. Of those market experts, the high estimate was -$0.33 and the low estimate was -$0.36. If the analysts are correct about the current quarter’s earnings, the growth will be -100.03% .

Turning our focus now to insider trading activity, there have been 17 purchases (129,134 shares in total) and 62 sale (571,106 shares in total) in the last 3 months. In the last 6 months, there have been 21 insider buys amounting to 2,334,896 shares and 67 insider sales amounting to 745,878 shares. In the past full year, 55 insider purchases were made (involving 57,156,345 shares) and 68 insider sell-offs equivalent to 748,261 shares.

Moving onto liquidity, Guardant Health, Inc. (GH) has a Current Ratio of 9.99, a Quick Ratio of 9.80 and a Cash Ratio of 8.92. Looking at this company’s capital structure, its Total Debt to Total Equity is 1.56, its Total Debt to Total Capital is 1.54, and its Total Debt to Total Assets is now 1.29. Looking even further ahead into the future, its Long-Term Debt to Equity is 1.54 and its Long-Term Debt to Total Capital is 1.52.